136 related articles for article (PubMed ID: 32094384)
21. Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells.
Konecny GE; Kolarova T; O'Brien NA; Winterhoff B; Yang G; Qi J; Qi Z; Venkatesan N; Ayala R; Luo T; Finn RS; Kristof J; Galderisi C; Porta DG; Anderson L; Shi MM; Yovine A; Slamon DJ
Mol Cancer Ther; 2013 May; 12(5):632-42. PubMed ID: 23443805
[TBL] [Abstract][Full Text] [Related]
22. Recombinant HE4 protein promotes proliferation of pancreatic and endometrial cancer cell lines.
Lu Q; Chen H; Senkowski C; Wang J; Wang X; Brower S; Glasgow W; Byck D; Jiang SW; Li J
Oncol Rep; 2016 Jan; 35(1):163-70. PubMed ID: 26497244
[TBL] [Abstract][Full Text] [Related]
23. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
[TBL] [Abstract][Full Text] [Related]
24. Role of serum HE4 as a prognostic marker in carcinoma of the ovary.
Lakshmanan M; Kumar V; Chaturvedi A; Misra S; Gupta S; Akhtar N; Rajan S; Jain K; Garg S
Indian J Cancer; 2019; 56(3):216-221. PubMed ID: 31389384
[TBL] [Abstract][Full Text] [Related]
25. The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells
Blum W; Henzi T; Pecze L; Diep KL; Bochet CG; Schwaller B
Oncotarget; 2019 Dec; 10(65):6944-6956. PubMed ID: 31857849
[TBL] [Abstract][Full Text] [Related]
26. Role of trypsin and protease-activated receptor-2 in ovarian cancer.
Kim KK; Turner R; Khazan N; Kodza A; Jones A; Singh RK; Moore RG
PLoS One; 2020; 15(5):e0232253. PubMed ID: 32365084
[TBL] [Abstract][Full Text] [Related]
27. Transformation products elucidation of forchlorfenuron in postharvest kiwifruit by time-of-flight mass spectrometry.
Zhang Z; Gao Z; Wang Y; Yuan Y; Dong J; Yue T
PLoS One; 2017; 12(9):e0184021. PubMed ID: 28877224
[TBL] [Abstract][Full Text] [Related]
28. PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2
Packer LM; Geng X; Bonazzi VF; Ju RJ; Mahon CE; Cummings MC; Stephenson SA; Pollock PM
Mol Cancer Ther; 2017 Apr; 16(4):637-648. PubMed ID: 28119489
[TBL] [Abstract][Full Text] [Related]
29. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H
J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance of HE4 and ROMA among Chinese women.
Shen Y; Zhao L; Lu S
Clin Chim Acta; 2020 Jan; 500():42-46. PubMed ID: 31626761
[TBL] [Abstract][Full Text] [Related]
31. Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30).
Yang Q; Guo X; Yang L
Med Sci Monit; 2018 Apr; 24():2225-2234. PubMed ID: 29654226
[TBL] [Abstract][Full Text] [Related]
32.
Rios-Valencia DG; López-Villegas EO; Diaz Chiguer D; Marquez Navarro A; Díaz-Martín RD; Nogueda-Torres B; Ambrosio JR
J Parasitol Res; 2019; 2019():8578936. PubMed ID: 30941206
[TBL] [Abstract][Full Text] [Related]
33. Fungal-Mediated Biotransformation of the Plant Growth Regulator Forchlorfenuron by
Moreno CM; Moreno JN; Valdez MC; Baldwin MP; Vallor AC; Carvalho PB
Metabolites; 2024 Feb; 14(2):. PubMed ID: 38392993
[TBL] [Abstract][Full Text] [Related]
34. Serum HE4 Level as a Biomarker to Predict the Recurrence of Gynecologic Cancers.
Li J; Chen H; Curcuru JR; Patel S; Johns TO; Patel D; Qian H; Jiang SW
Curr Drug Targets; 2017; 18(10):1158-1164. PubMed ID: 28382859
[TBL] [Abstract][Full Text] [Related]
35. Septin dynamics are essential for exocytosis.
Tokhtaeva E; Capri J; Marcus EA; Whitelegge JP; Khuzakhmetova V; Bukharaeva E; Deiss-Yehiely N; Dada LA; Sachs G; Fernandez-Salas E; Vagin O
J Biol Chem; 2015 Feb; 290(9):5280-97. PubMed ID: 25575596
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy.
Itamochi H; Kigawa J; Kanamori Y; Oishi T; Bartholomeusz C; Nahta R; Esteva FJ; Sneige N; Terakawa N; Ueno NT
Mol Cancer Ther; 2007 Jan; 6(1):227-35. PubMed ID: 17218636
[TBL] [Abstract][Full Text] [Related]
37. HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.
Espiau Romera A; Cuesta Guardiola T; Benito Vielba M; De Bonrostro Torralba C; Coronado Martín PJ; Baquedano Mainar L
Int J Gynaecol Obstet; 2020 Jun; 149(3):265-268. PubMed ID: 32147821
[TBL] [Abstract][Full Text] [Related]
38. A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge.
Ge L; Liu G; Hu K; Huang K; Zhang M; Zhou J; Teng F; Cao J; Dai C; Jia X
Technol Cancer Res Treat; 2020; 19():1533033819901117. PubMed ID: 32167027
[TBL] [Abstract][Full Text] [Related]
39. The role of the HER-2/neu oncogene in gynecologic cancers.
Cirisano FD; Karlan BY
J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
[TBL] [Abstract][Full Text] [Related]
40. Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.
Wang H; Zhu L; Gao J; Hu Z; Lin B
Oncol Rep; 2015 Jan; 33(1):403-12. PubMed ID: 25354091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]